Plain-English translation of NCT07779486 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether intravenous magnesium sulfate—a mineral that may help calm overactive nerve activity and reduce pain—can effectively treat severe acute headaches in the emergency department. Researchers want to find out if magnesium sulfate works better than paracetamol (a standard pain reliever) and whether a higher dose might be more effective than a lower dose.
Many people come to emergency departments with severe headaches, but current pain medications don't always work well enough. This medication shows promise because it may target the root causes of headaches by affecting nerve signals and blood vessel function, but doctors need to know if it really works and what dose is best.
You likely qualify if…
You likely don't qualify if…
You would visit the emergency department with your headache and be randomly assigned to receive one of three intravenous treatments: a lower dose of magnesium sulfate, a higher dose of magnesium sulfate, or paracetamol. The medication would be given through an IV over 10–15 minutes. Your pain level would be measured at 60 minutes after treatment, and the research team would track whether you need additional pain relief, check for any side effects, and monitor how long you stay in the emergency department.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
Tunisia